Transrectal high-intensity focused ultrasound (HIFU) was recently esta
blished as a highly effective means of inducing contact and irradiatio
n-free intraprostatic coagulative necrosis. This technique, therefore,
appears potentially useful for treating Localized prostate cancer (PC
). To evaluate this issue, a total of 29 human prostates with localize
d cancer was subjected to HIFU treatment in vivo before radical retrop
ubic prostatectomy. HIFU therapy was performed with the use of HIFU tr
ansducers with focal lengths of 3.0 cm (n = 3), 3.5 cm (n = 19), and 4
.0 cm (n = 7), and the site intensity was varied from 1260 to 2000 W/c
m(2). The extent of intraprostatic necrosis was determined by planimet
rical analysis of whole mount prostatic sections. Transrectal HIFU con
sistently induced sharply delineated intraprostatic coagulative necros
is within the target area, whereas alterations of periprostatic struct
ures were never observed. The cross-sectional area of necrosis increas
ed from 1.1 +/- 0.7 cm(2) (SD; n = 3; 3.0-cm focal length; 1428 W/cm(2
)) to 1.2 +/- 0.7 cm(2) (n = 2; 3.5-cm focal length; 1428 W/cm(2)), 1.
8 +/- 0.17 cm(2) (n = 8; 3.5-cm focal length; 1680 W/cm(2)), 2.8 +/- 0
.32 cm(2) (n = 9; 3.5-cm focal length; 2000 W/cm(2)) and 3.8 +/- 0.4 c
m(2) (n = 7; 4.0 cm focal length; 1260 W/cm(2)). HIFU beam transmissio
n and the therapeutic effect were comparable in benign and malignant p
rostatic tissue. Interstitial thermometry (n = 6) revealed maximum int
raprostatic temperatures in the focal zone up to 98.6 degrees C. Outsi
de the focal zone and on the rectal wall, no significant temperature r
ises were noted. Subsequently, HIFU was applied to unilateral histolog
ically proven T-2n/T-2b PC (12 = 10) in an attempt to destroy all canc
er before radical retropubic prostatectomy. PC was always correctly ta
rgeted. In 7 individuals, PC was partially (mean, 53%; range, 38-77%)
destroyed; in the remaining 3 cases the entire tumor was ablated. Alth
ough these histological data permit no definitive conclusion on the cl
inical efficacy of this approach, transrectal HIFU seems to be a an at
tractive novel minimally invasive treatment option for localized PC.